Abeona Therapeutics Stock (NASDAQ: ABEO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.78K / 322.39K |
Day Range | - - - |
52 Wk Range | 3.05 - 9.01 |
Market Cap | $267.68M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 70 |
Short Interest | 6.78% |
Days to Cover | 11.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Abeona Therapeutics (NASDAQ:ABEO) through any online brokerage.
Other companies in Abeona Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Abeona Therapeutics has a consensus price target of $16.00.
The stock price for Abeona Therapeutics (NASDAQ: ABEO) is $6.18 last updated September 23, 2024 at 8:37 AM EDT.
There are no upcoming dividends for Abeona Therapeutics.
Abeona Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Abeona Therapeutics.
Abeona Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.